Polyp Clinical Trials in Chicago, Illinois
9 recruitingChicago, Illinois
Showing 1–9 of 9 trials
Recruiting
Phase 3
A Phase 3 Study to Assess the Efficacy, Safety, and Tolerability of Itepekimab (Anti-IL-33 mAb) in Participants With Inadequately-controlled Chronic Rhinosinusitis With Nasal Polyps
Chronic Rhinosinusitis With Nasal Polyps
Sanofi210 enrolled121 locationsNCT06834347
Recruiting
Phase 3
A Phase 3 Study to Assess the Efficacy, Safety, and Tolerability of Itepekimab (Anti-IL-33 mAb) in Participants With Inadequately-controlled Chronic Rhinosinusitis With Nasal Polyps
Chronic Rhinosinusitis With Nasal Polyps
Sanofi210 enrolled113 locationsNCT06834360
Recruiting
Phase 3
A Study to Investigate Changes in Symptoms in Adult Participants With Chronic Rhinosinusitis With Nasal Polyposis Initiating Treatment With Tezepelumab
Chronic Rhinosinusitis With Nasal Polyps
AstraZeneca180 enrolled45 locationsNCT06706817
Recruiting
Phase 3
A Study of Lebrikizumab (LY3650150) in Participants With Chronic Rhinosinusitis and Nasal Polyps Treated With Intranasal Corticosteroids (CONTRAST-NP)
Chronic Rhinosinusitis With Nasal Polyps (CRSwNP)
Eli Lilly and Company510 enrolled194 locationsNCT06338995
Recruiting
Phase 3
OPN-375 Efficacy and Safety in Adolescents With Bilateral Nasal Polyps
Bilateral Nasal Polyposis
Optinose US Inc.72 enrolled40 locationsNCT03747458
Recruiting
Phase 3
Phase 3 Trial of eRapa in Patients With Familial Adenomatous Polyposis
Familial Adenomatous Polyposis (FAP)
Rapamycin Holdings Inc.168 enrolled26 locationsNCT06950385
Recruiting
Not Applicable
Colonoscopy vs Stool Testing for Older Adults With Colon Polyps
Colorectal NeoplasmsColorectal PolypColorectal Adenoma
Dartmouth-Hitchcock Medical Center8,946 enrolled19 locationsNCT05612347
Recruiting
CRS Questionnaire Validation Project
Chronic Rhinosinusitis (CRS) With and Without Nasal Polyps
The European Forum for Research and Education in Allergy and Airway Diseases1,000 enrolled32 locationsNCT06970977
Recruiting
Olfactory Cleft Obstruction and Electrophysiological Field Potentials Predict Olfactory Restoration by Dupilumab in CRSwNP Patients.
Smell LossChronic Rhinosinusitis Phenotype With Nasal Polyps (CRSwNP)
Northwestern University30 enrolled1 locationNCT06892704